LRRC4 and ovarian dysfunction: To determine whether LRRC4 treatment can alleviate ovarian insufficiency, we established a POI‐like mouse model by CTX and reinforced LRRC4 via the intraperitoneal injection of adeno‐associated virus (AAV)–LRRC4.